Innate Pharma S.A. carries a market capitalization of 154.94M, placing it among publicly traded companies globally.
| Market Cap | 154.94M |
| Enterprise Value | N/A |
Innate Pharma S.A.'s stock has gained approximately 25.9542% over the past 52 weeks. The 50-day moving average sits at 1.73, while the 200-day moving average is 1.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25.9542% |
| 50-Day Moving Average | 1.73 |
| 200-Day Moving Average | 1.89 |
| Average Volume (20 Days) | N/A |